These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8391902)

  • 21. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid.
    Sackmann M; Pauletzki J; Aydemir U; Holl J; Sauerbruch T; Hasford J; Paumgartner G
    Hepatology; 1991 Dec; 14(6):1136-41. PubMed ID: 1959863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones.
    Sylwestrowicz TA; Shaffer EA
    Gastroenterology; 1988 Sep; 95(3):740-8. PubMed ID: 3396819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Per oral gallstone dissolution therapy].
    Sugata F
    Nihon Rinsho; 1993 Jul; 51(7):1785-90. PubMed ID: 8366596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gallstone dissolution with oral bile acid therapy. Importance of pretreatment CT scanning and reasons for nonresponse.
    Pereira SP; Veysey MJ; Kennedy C; Hussaini SH; Murphy GM; Dowling RH
    Dig Dis Sci; 1997 Aug; 42(8):1775-82. PubMed ID: 9286247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does computed tomography improve patients selection for extracorporeal shock wave lithotripsy (ESWL) of radiolucent gallbladder stones?
    Franke F; Sackmann M; Holl J; Pauletzki J; Neubrand M; Paumgartner G; Sauerbruch T
    Z Gastroenterol; 1992 Mar; 30(3):180-2. PubMed ID: 1590013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of cholesterol gallstones with litholytic bile acids.
    Salen G; Tint GS; Shefer S
    Gastroenterol Clin North Am; 1991 Mar; 20(1):171-82. PubMed ID: 2022420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical dissolution of gallstones by ursodeoxycholic acid: a clinical trial on 14 patients.
    Lin JT; Wang JT; Wang TH; Su CT
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):370-6. PubMed ID: 2794937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
    Meredith TJ; Williams GV; Maton PN; Murphy GM; Saxton HM; Dowling RH
    Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of computerized tomography in the densitometric assessment of lithiasis of the gallbladder].
    Polverosi R; Sbeghen R; Zambelli C; Caracciolo F; Spigariol F; Caroli A
    Radiol Med; 1992 Oct; 84(4):387-92. PubMed ID: 1455020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiological and ultrasonographic investigations with respect to patient selection and monitoring for chemical gallstone dissolution.
    Leuschner M; Leuschner U; Strohm WD; Trüber E; Fuchs H; Classen M
    Hepatogastroenterology; 1984 Jun; 31(3):140-3. PubMed ID: 6469205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O; von Bergmann K
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group.
    Petroni ML; Jazrawi RP; Pazzi P; Lanzini A; Zuin M; Pigozzi MG; Fracchia M; Galatola G; Alvisi V; Heaton KW; Podda M; Northfield TC
    Aliment Pharmacol Ther; 2001 Jan; 15(1):123-8. PubMed ID: 11136285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recurrent gallstones and possibilities for treatment after successful gallstone dissolution].
    Tudyka J; Wechsler JG; Kratzer W; Ernst S; Mack C; Janowitz P; Ditschuneit H
    Med Klin (Munich); 1991 Nov; 86(11):585-8, 606. PubMed ID: 1770899
    [No Abstract]   [Full Text] [Related]  

  • 35. Dissolution of gallstones--when and how?
    Tangedahl T
    Surg Clin North Am; 1979 Oct; 59(5):797-809. PubMed ID: 390740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracorporeal shock wave lithotripsy of gallstones: early experience in an Israeli population.
    Moshkowitz M; Erlich N; Halpern Z; Gilat T
    Isr J Med Sci; 1993 Nov; 29(11):677-9. PubMed ID: 8270393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gallstone dissolution].
    Leuschner U
    Internist (Berl); 1980 Oct; 21(10):607-16. PubMed ID: 7005153
    [No Abstract]   [Full Text] [Related]  

  • 39. Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstones.
    Fromm H
    J Clin Gastroenterol; 1988; 10 Suppl 2():S18-21. PubMed ID: 3062080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cholelitholysis--gallbladder sediments and pigment stones].
    Wolpers C; Wosiewitz U
    Leber Magen Darm; 1985 Mar; 15(2):64-70. PubMed ID: 3990499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.